The Medical Letter on Drugs and Therapeutics
FROM
ISSUE921
ISSUE921
April 29, 1994
Gabapentin - A New Anticonvulsant
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Gabapentin - A New Anticonvulsant
April 29, 1994 (Issue: 921)
Gabapentin (Neurontin - Parke-Davis), a cyclohexane acetic acid derivative, has been approved by the US Food and Drug Administration for use in addition to other antiepileptic drugs in patients with partial (focal) seizures with or without...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.